查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
动物疼痛管理市场-按产品类型、应用、动物类型、地区和竞争对手分列的全球行业规模、份额、趋势、机会和预测（2018-2028 年）
市场调查报告书
商品编码
1244146

动物疼痛管理市场-按产品类型、应用、动物类型、地区和竞争对手分列的全球行业规模、份额、趋势、机会和预测（2018-2028 年）

Veterinary Pain Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Product, By Application, By Animal Type, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 119 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球兽医疼痛管理市场预计在预测期内将出现令人瞩目的增长。

这是由于动物种群中炎症和疼痛性疾病（如缺陷、遗传疾病和生理疾病）的发病率增加所致。 此外，城市地区对易于获得和负担得起的治疗的需求不断增长，以及动物健康和福利意识的提高正在推动世界各地对兽医疼痛管理的需求，并显着增加。 此外，越来越多的牲畜患有癌症、腹痛和神经性疼痛，这将增加对各种动物疼痛管理的需求，预计这将推动市场增长到 2028 年。 治疗动物疼痛原因的研究和开发活动也有所增加，包括全球范围内的各种治疗方式，预计这将在预测期内进一步支持动物疼痛管理市场。 Veterinary Practice News 于 2020 年 6 月发表的一篇文章发现，全世界狗的骨关节炎患病率为 20%。 同样，根据美国动物健康协会 2021 年 4 月发表的一篇文章，每年大约有 600 万隻狗被诊断出患有癌症。

慢性病患病率增加

世界各地动物急性和慢性疾病发病率上升是预测期内推动市场增长的主要因素之一。 例如，动物缺乏症、遗传疾病（包括遗传和非遗传疾病）和生理疾病等传染病发病率的增加将在未来几年积极推动市场的增长。我在这里。 此外，由于包括传染病在内的动物疾病日益流行，人们对兽医疼痛管理疗法的认识和需求不断提高。 根据美国宠物用品协会 (APPA) 进行的 2021-2022 年全国宠物主人调查，70% 的美国家庭，即大约 9050 万户家庭拥有宠物。 同样，门诊诊所越来越需要适应越来越多的外科手术，预计在预测期内将产生显着增长。

增加对宠物保健的投资

在预测期内，更加註重改善宠物医疗设施和医疗基础设施是推动兽医疼痛管理市场增长的主要因素。 与公共机构和私营公司的战略伙伴关係和合作越来越多，以开发和应用新技术和改进的技术。 这进一步扩大了未来几年市场机会的多样性。 此外，政府加大力度提高人们对早期诊断价值的认识，也再次提振了市场。 增加对医疗设备和设备的研发投资，特别是在发达和新兴经济体，将在预测期内进一步创造有利可图的市场扩张前景。 2021 年美国投保的宠物总数将达到 390 万隻，比 2020 年增长 28%。 非药物疼痛管理技术的日益普及也是市场增长的主要驱动力，对用于疼痛管理的激光和电磁疗法的需求不断增长预计将推动市场增长多年。。

市场细分

近期发展

  • 2021 年 2 月，根据与 Animal Ethics Pty Ltd 的许可协议，Dechra Pharmaceuticals PLC 获得了 Tri-Solfen 在澳大利亚和新西兰的商业权利。 Tri-Solfen 被用作减轻家畜疼痛的常规药物。
  • 2020 年 7 月，勃林格殷格翰收购了比利时生物技术公司 GST，以加强其在动物健康领域的干细胞能力。

市场进入者

Boehringer Ingelheim International GmbH、Zoetis Inc、Elanco Animal Health Incorporated、Norbrook Laboratories Limited、SeQuent Scientific Limited、Merck & Co. Inc、Decra Pharmaceuticals Plc、Vetoquinol S.A、Ceva Sante Animale SA、Chanelle Pharma Group Ltd 这是一个示例在疼痛管理市场经营的一些主要参与者。

范围

这份报告将全球动物疼痛管理市场分为以下几类，以及下面详述的行业趋势：

兽医疼痛管理市场，按产品分类：

  • 药物治疗
  • 医疗设备

兽医疼痛管理市场，按应用：

  • 关节痛
  • 癌痛
  • 术后疼痛
  • 其他

按动物类型划分的动物疼痛管理市场：

  • 伴侣动物
  • 家畜

按地区划分的兽医疼痛管理市场：

  • 北美
    • 美国
    • 墨西哥
    • 加拿大
  • 欧洲
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥伦比亚
  • 中东和非洲
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • 埃及
    • 土耳其人

竞争格局

公司简介：对全球动物疼痛管理市场主要参与者的深入分析。

可自定义：

根据市场数据，TechSci Research 根据公司的具体需求提供定制服务。 该报告可以定制为：

公司信息

  • 对其他市场参与者（最多 5 家公司）进行深入分析和概况分析。

内容

第 1 章概述

  • 市场定义
  • 市场范围
    • 目标市场
    • 研究目标年份
    • 主要市场细分

第二章研究方法论

  • 调查目的
  • 基线调查方法
  • 主要行业合作伙伴
  • 主要协会和次要信息
  • 调查方法
  • 数据三角测量和验证
  • 假设和限制

第 3 章执行摘要

  • 市场概览
  • 主要市场细分概述
  • 主要市场参与者概览
  • 主要地区/国家概览
  • 市场驱动因素、挑战和趋势概述

第 4 章 VOC（客户之声）

第 5 章全球动物疼痛管理市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按产品（药品/医疗器械）
    • 按应用（关节痛、癌症疼痛、术后疼痛等）
    • 按动物类型（伴侣动物/家畜）
    • 按地区
    • 按公司分类（2022 年）
  • 市场地图
    • 按产品分类
    • 通过申请
    • 按动物类型
    • 按地区

第 6 章北美动物疼痛管理市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按产品（药品/医疗器械）
    • 按应用（关节痛、癌症疼痛、术后疼痛等）
    • 按动物类型（伴侣动物/家畜）
    • 按国家
  • 北美：国家/地区分析
    • 美国
    • 墨西哥
    • 加拿大

第 7 章欧洲动物疼痛管理市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按产品（药品/医疗器械）
    • 按应用（关节痛、癌症疼痛、术后疼痛等）
    • 按动物类型（伴侣动物/家畜）
    • 按国家
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第 8 章亚太动物疼痛管理市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按产品（药品/医疗器械）
    • 按应用（关节痛、癌症疼痛、术后疼痛等）
    • 按动物类型（伴侣动物/家畜）
    • 按国家
  • 亚太地区：国家/地区分析
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚

第 9 章南美动物疼痛管理市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按产品（药品/医疗器械）
    • 按应用（关节痛、癌症疼痛、术后疼痛等）
    • 按动物类型（伴侣动物/家畜）
    • 按国家
  • 南美洲：：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章中东和非洲动物疼痛管理市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按产品（药品/医疗器械）
    • 按应用（关节痛、癌症疼痛、术后疼痛等）
    • 按动物类型（伴侣动物/家畜）
    • 按国家
  • MEA：国家分析
    • 南非动物的疼痛管理
    • 沙特阿拉伯兽医疼痛管理
    • 阿联酋兽医疼痛管理
    • 埃及动物疼痛管理
    • 土耳其兽医疼痛管理

第 11 章市场动态

  • 司机
  • 做

第12章市场趋势与发展

  • 近期趋势
  • M&A（併购）
  • 产品发布

第13章竞争格局

  • Business Overview
  • Product Offerings
  • Recent Developments
  • Financials（As Reported）
  • Key Personnel
  • SWOT Analysis
    • Boehringer Ingelheim International GmbH
    • Zoetis Inc.
    • Elanco Animal Health Incorporated
    • Norbrook Laboratories Limited
    • SeQuent Scientific Limited
    • Merck & Co., Inc.
    • Dechra Pharmaceuticals Plc
    • Vetoquinol S.A.
    • Ceva Sante Animale SA
    • Chanelle Pharma Group Ltd.

第14章 战略建议

简介目录
Product Code: 14422

Global veterinary pain management market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing incidence of inflammatory and painful diseases such as deficiency disease, hereditary diseases, and physiological diseases in the animal population. Additionally, growing the need for easily accessible and affordable treatment procedures in urban regions and growing awareness about animal health and welfare have significantly enhanced the demand for veterinary pain management across different parts of the globe. Additionally, increasing the livestock population suffering from cancer, abdominal pain, and neuropathic pain is expected to boost the demand for different veterinary pain management, thereby fuelling the market growth through 2028. Besides, increasing research and development activities to treat various causes of pain in animals including different therapy across the globe is further expected to support the veterinary pain management market during the forecast period. According to an article published by Veterinary Practice News in June 2020, the prevalence of osteoarthritis in dogs was found to be 20% globally. Similarly, according to an article published by American Animal Health Association in April 2021, approximately 6 million dogs are diagnosed with cancer each year.

Growing Prevalence of Chronic Diseases

The increasing rate of acute and chronic diseases in animals across the globe is one of the major factors bolstering the growth of the market in the forecast period. For example, the growing incidence rate of infectious diseases such as deficiency diseases, hereditary diseases (including both genetic diseases and non-genetic hereditary diseases), and physiological diseases in animals is positively enhancing the growth of the market over the coming years. Also, due to the increasing prevalence of animal diseases which also includes epizootic diseases, there is a greater awareness and rising need for veterinary pain management therapy. Seventy percent of U.S. households, or about 90.5 million families, own a pet, according to the 2021-2022 National Pet Owners Survey conducted by the American Pet Products Association (APPA). Similarly, the growing need for outpatient clinics to meet the rising volume of surgical procedures is expected to create significant growth during the forecasted period.

Increasing Investment in the Pet Healthcare Sector

Growing focus on improving the pet healthcare facilities and overall healthcare infrastructure is a major factor boosting the growth of the veterinary pain management market in the forecast period. To develop and apply new and improved technologies, there are an increasing number of strategic partnerships and collaborations with both public and private organizations. This is further expanding the diversity of market opportunities for the coming years. Additionally, the government's rising efforts to raise awareness of the value of early diagnosis are once again fuelling the market's expansion. Increasing investment in R&D, particularly in established and developing economies, about medical instruments and devices will further generate profitable market expansion prospects over the projection period. The total number of pets insured in the U.S. in 2021 was 3.9 million, a 28 percent increase since 2020. Also, the growing popularity of nonpharmaceutical pain management techniques is a major factor in the growth of the market, and the growing demand for laser therapy and electromagnetic therapy as pain management is anticipated to drive the growth of the market over the years.

Market Segmentation

Global veterinary pain management market can be segmented by product, application, animal type, and by region. Based on product, the market can be divided into Medications and Medical Devices. Based on application, the market can be differentiated into Joint Pain, Cancer Pain, Postoperative Pain, and Others. Based on application, the market can be divided into Companion Animals and Livestock animals. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East and Africa, and South America. Among the different countries, United States dominated the global veterinary pain management market on account of the growing incidence of animal diseases in the country.

Recent Development

  • In February 2021, Dechra Pharmaceuticals PLC received rights for marketing Tri-Solfen in Australia and New Zealand under a licensing agreement with Animal Ethics Pty Ltd. Tri-Solfen is used as a routine treatment in reducing pain for farm animals.
  • In July 2020, Boehringer Ingelheim acquired a Belgian biotech company, GST, to strengthen its stem cell capabilities in the Animal Health segment.

Market Players

Boehringer Ingelheim International GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Norbrook Laboratories Limited, SeQuent Scientific Limited, Merck & Co., Inc., Dechra Pharmaceuticals Plc, Vetoquinol S.A., Ceva Sante Animale SA, Chanelle Pharma Group Ltd are some of the leading players operating in the global veterinary pain management market.

Report Scope:

In this report, global veterinary pain management market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Pain Management Market, By Product:

  • Medications
  • Medical Devices

Veterinary Pain Management Market, By Application:

  • Joint Pain
  • Cancer Pain
  • Postoperative Pain
  • Others

Veterinary Pain Management Market, By Animal Type:

  • Companion Animal
  • Livestock Animal

Veterinary Pain Management Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Veterinary Pain Management Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Pain Management Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Medications v/s Medical Devices)
      • 5.2.1.1. By Medication (NSAIDS, Opioids, Local anaesthetics, Alpha-2 agonists, Others)
      • 5.2.1.2. By Medical Devices (Laser Therapy Device v/s Electromagnetic Device)
    • 5.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
    • 5.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
      • 5.2.3.1. By Companion Animal (Dog, Cat, Horse, Others)
      • 5.2.3.2. By Livestock Animal (Cattle, Swine, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Market Map
    • 5.3.1. By Product
    • 5.3.2. By Application
    • 5.3.3. By Animal Type
    • 5.3.4. By Region

6. North America Veterinary Pain Management Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Medications v/s Medical Devices)
      • 6.2.1.1. By Medication (NSAIDS, Opioids, Local anaesthetics, Alpha-2 agonists, Others)
      • 6.2.1.2. By Medical Devices (Laser Therapy Device v/s Electromagnetic Device)
    • 6.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
    • 6.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
      • 6.2.3.1. By Companion Animal (Dog, Cat, Horse, Others)
      • 6.2.3.2. By Livestock Animal (Cattle, Swine, Others)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Veterinary Pain Management Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By Animal Type
    • 6.3.2. Mexico Veterinary Pain Management Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By Animal Type
    • 6.3.3. Canada Veterinary Pain Management Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By Animal Type

7. Europe Veterinary Pain Management Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Medications v/s Medical Devices)
      • 7.2.1.1. By Medication (NSAIDS, Opioids, Local anaesthetics, Alpha-2 agonists, Others)
      • 7.2.1.2. By Medical Devices (Laser Therapy Device v/s Electromagnetic Device)
    • 7.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
    • 7.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
      • 7.2.3.1. By Companion Animal (Dog, Cat, Horse, Others)
      • 7.2.3.2. By Livestock Animal (Cattle, Swine, Others)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Veterinary Pain Management Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Animal Type
    • 7.3.2. Germany Veterinary Pain Management Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Animal Type
    • 7.3.3. United Kingdom Veterinary Pain Management Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Animal Type
    • 7.3.4. Italy Veterinary Pain Management Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Animal Type
    • 7.3.5. Spain Veterinary Pain Management Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Animal Type

8. Asia-Pacific Veterinary Pain Management Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Medications v/s Medical Devices)
      • 8.2.1.1. By Medication (NSAIDS, Opioids, Local anaesthetics, Alpha-2 agonists, Others)
      • 8.2.1.2. By Medical Devices (Laser Therapy Device v/s Electromagnetic Device)
    • 8.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
    • 8.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
      • 8.2.3.1. By Companion Animal (Dog, Cat, Horse, Others)
      • 8.2.3.2. By Livestock Animal (Cattle, Swine, Others)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Veterinary Pain Management Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Animal Type
    • 8.3.2. India Veterinary Pain Management Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Animal Type
    • 8.3.3. South Korea Veterinary Pain Management Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Animal Type
    • 8.3.4. Japan Veterinary Pain Management Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Animal Type
    • 8.3.5. Australia Veterinary Pain Management Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Animal Type

9. South America Veterinary Pain Management Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Medications v/s Medical Devices)
      • 9.2.1.1. By Medication (NSAIDS, Opioids, Local anaesthetics, Alpha-2 agonists, Others)
      • 9.2.1.2. By Medical Devices (Laser Therapy Device v/s Electromagnetic Device)
    • 9.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
    • 9.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
      • 9.2.3.1. By Companion Animal (Dog, Cat, Horse, Others)
      • 9.2.3.2. By Livestock Animal (Cattle, Swine, Others)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Veterinary Pain Management Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Animal Type
    • 9.3.2. Argentina Veterinary Pain Management Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Animal Type
    • 9.3.3. Colombia Veterinary Pain Management Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Animal Type

10. Middle East and Africa Veterinary Pain Management Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Medications v/s Medical Devices)
      • 10.2.1.1. By Medication (NSAIDS, Opioids, Local anaesthetics, Alpha-2 agonists, Others)
      • 10.2.1.2. By Medical Devices (Laser Therapy Device v/s Electromagnetic Device)
    • 10.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
    • 10.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
      • 10.2.3.1. By Companion Animal (Dog, Cat, Horse, Others)
      • 10.2.3.2. By Livestock Animal (Cattle, Swine, Others)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Veterinary Pain Management Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Animal Type
    • 10.3.2. Saudi Arabia Veterinary Pain Management Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Animal Type
    • 10.3.3. UAE Veterinary Pain Management Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Animal Type
    • 10.3.4. Egypt Veterinary Pain Management Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Product
        • 10.3.4.2.2. By Application
        • 10.3.4.2.3. By Animal Type
    • 10.3.5. Turkey Veterinary Pain Management Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Product
        • 10.3.5.2.2. By Application
        • 10.3.5.2.3. By Animal Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Competitive Landscape

  • 13.1. Business Overview
  • 13.2. Product Offerings
  • 13.3. Recent Developments
  • 13.4. Financials (As Reported)
  • 13.5. Key Personnel
  • 13.6. SWOT Analysis
    • 13.6.1. Boehringer Ingelheim International GmbH
    • 13.6.2. Zoetis Inc.
    • 13.6.3. Elanco Animal Health Incorporated
    • 13.6.4. Norbrook Laboratories Limited
    • 13.6.5. SeQuent Scientific Limited
    • 13.6.6. Merck & Co., Inc.
    • 13.6.7. Dechra Pharmaceuticals Plc
    • 13.6.8. Vetoquinol S.A.
    • 13.6.9. Ceva Sante Animale SA
    • 13.6.10. Chanelle Pharma Group Ltd.

14. Strategic Recommendations